Baxter Ventures invests in VitalConnect
Client(s) Baxter Ventures
Jones Day represented Baxter Ventures in connection with its purchase of Series C Preferred Stock in a private placement by VitalConnect, a leader in medical-grade wearable biosensor systems. MVM Life Science Partners LLP acted as a co-investor.